Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure.

Full Abstract

Many hepatitis C virus (HCV) infections worldwide are with the genotype 1 and 3 strains of the virus. Cellular immune responses are known to be important in the containment of HCV genotype 1 infection, and many genotype 1 T cell targets (epitopes) that are presented by host human leukocyte antigens (HLAs) have been identified. In contrast, there is almost no information known about the equivalent responses to genotype 3. Immune escape mechanisms used by HCV include the evolution of viral polymorphisms (adaptations) that abrogate this host-viral interaction. Evidence of HCV adaptation to HLA-restricted immune pressure on HCV can be observed at the population level as viral polymorphisms associated with specific HLA types. To evaluate the escape patterns of HCV genotypes 1 and 3, we assessed the associations between viral polymorphisms and specific HLA types from 187 individuals with genotype 1a and 136 individuals with genotype 3a infection. We identified 51 HLA-associated viral polymorphisms (32 for genotype 1a and 19 for genotype 3a). Of these putative viral adaptation sites, six fell within previously published epitopes. Only two HLA-associated viral polymorphisms were common to both genotypes. In the remaining sites with HLA-associated polymorphisms, there was either complete conservation or no significant HLA association with viral polymorphism in the alternative genotype. This study also highlights the diverse mechanisms by which viral evasion of immune responses may be achieved and the role of genotype variation in these processes. CONCLUSION: There is little overlap in HLA-associated polymorphisms in the nonstructural proteins of HCV for the two genotypes, implying differences in the cellular immune pressures acting on these viruses and different escape profiles. These findings have implications for future therapeutic strategies to combat HCV infection, including vaccine design.

Author information

Author/s: Rauch, Andri (A); James, Ian (I); Pfafferott, Katja (K); Nolan, David (D); Klenerman, Paul (P); Cheng, Wendy (W); Mollison, Lindsay (L); McCaughan, Geoff (G); Shackel, Nick (N); Jeffrey, Gary P (GP); Baker, Ross (R); Freitas, Elizabeth (E); Humphreys, Isla (I); Furrer, Hansjakob (H); Günthard, Huldrych F (HF); Hirschel, Bernard (B); Mallal, Simon (S); John, Mina (M); Lucas, Michaela (M); Barnes, Eleanor (E); Gaudieri, Silvana (S);

Affiliation: University Clinic of Infectious Diseases, University Hospital Bern and University of Bern, Bern, Switzerland.

Journal and publication information

Publication Type: Comparative Study; Journal Article; Multicenter Study

Journal: Hepatology (Baltimore, Md.) (Hepatology), published in United States. (Language: eng)

Reference: 2009-Oct; vol 50 (issue 4) : pp 1017-29

Dates: Created 2009/10/05; Completed 2009/10/20;

PMID: 19670417, status: MEDLINE (last retrieval date: 10/20/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.